The Royal College of Veterinary Surgeons is warning practices and would be veterinary nurse students to check that VN training courses are approved by the College, or they will not lead to qualification as a veterinary nurse.
The RCVS has reported one such course, run by Direct Veterinary Services of Oxford (http://www.direct-vets.com/), to Trading Standards: it advertises 'accredited training for veterinary nurses' leading to 'an honours degree in veterinary nursing' without being an RCVS-approved training provider or awarding organisation.
RCVS Head of Veterinary Nursing, Libby Earle said: "Would-be veterinary nurse students should always check that the course they are embarking upon will lead to a qualification that is recognised by the RCVS for the purposes of registration, or they may be in for a disappointment.
"Only those courses approved by the RCVS will lead to registration, and without registration (or listing), individuals should not call themselves veterinary nurses and cannot legally carry out medical procedures and minor surgery under Schedule 3 to the Veterinary Surgeons Act."
The College says candidates should also be wary of training providers who demand money upfront online.
All new veterinary nursing courses and qualifications must be approved by the RCVS and this process can take some time. The list of approved centres providing VN training courses, together with details of approved qualifications, are available at: http://awardingbody.rcvs.org.uk/,
VetSurgeon member Anthony Todd has started a petition amongst veterinary surgeons and nurses, calling for the installation and routine monitoring of CCTV in all pre-slaughter areas of licensed abattoirs in the UK.
The petition was triggered by a news report in the Daily Mail exposing shocking cruelty to pigs at an Essex slaughterhouse run by Cheale Meats. Staff were seen stubbing their cigarettes out on the pigs' faces, punching them and failing to stun the animals correctly, in undercover footage filmed by Animal Aid.
The Food Standards Agency, which is responsible for breaches of welfare at abattoirs, has refused to submit the footage to Defra for prosecution, on the basis that it was filmed illegally.
Anthony said: "Prosecution will automatically follow with legal video evidence.
"The exposure of the Cheale incident was fortuitous and may well be the tip of the iceberg which must be eliminated."
To sign the petition, please visit: http://www.ipetitions.com/petition/abbatoir-abuse/
The BVA is now reaching out to non-members with a three-month, no strings attached, free trial. The offer ends on 31 August.
Over the past few years the BVA membership package has changed significantly in response to the needs of veterinary surgeons across the UK at all stages of their careers.
Harvey Locke, BVA President, said: "The well-documented stresses that put members of our profession at risk of mental health problems are unacceptably high. With their focus on conflict resolution and individual support, however, we hope the BVA legal services will come to be seen as a safety net for BVA members should things go wrong at work.
"These kinds of employment issues can be hard to talk about so we hope by highlighting a few stories it will encourage others to seek the help they need from the BVA.
"The three-month free trial is an opportunity for the BVA to reach out to non-members and show them the impact of our complete membership package - from the legal and employment services and free and discounted CPD to our popular publications and money-saving financial services."
Bayer Animal Health has announced that following the success of its educational TV advertising campaign, which ran earlier this year and promoted the need to worm cats, a second advertising campaign will now run in September.
Bayer (makers of Profender Spot-on solution) says its first campaign, which ran in May, had the principal aim of driving pet owners to their vet to ask about spot-on worming for their cats.
As part of the same campaign, research was conducted on cat behaviour by interviewing cat owners and attaching 'cat cams' and 'cat navs' to nine cats around the country. The results were analysed by cat behaviour expert Roger Tabor and can be found on the website www.spotonwormer4cats.com/, both as a short video documentary and a 24-page report, entitled 'The Secret Lives of Cats'.
A consumer PR campaign was also run in parallel with the TV advertising, which Bayer says was very successful in attracting entrants to a competition to find the cat with the biggest personality. Winners of the Cats with Cat-titude competition have now been announced and profiled on www.spotonwormer4cats.com.
Dan White, Profender product manager, said: "Post campaign market research revealed there was a 5% increase in the awareness of spot-on cat worming.
"The second phase of TV advertising - using the same advert but without the online competition - will start on 4th September and will build on the success of the previous advertising. And over the following three weeks, it will be broadcast on ITV1, ITV2, Channels 4 and 5, and Sky One, and is expected to reach 7 million of our core target audience."
Veterinary practices can obtain a subtitled version of 'The Secret Lives of Cats' documentary to play in their waiting rooms, and a wide selection of support materials, by contacting their Bayer Territory Manager.
A new session has been added to Ceva Animal Health UK's Cardio Academy CPD website entitled "Thoracic X-rays: Abnormal Features".
In the 30 minute multimedia presentation, the cardiology specialist Nicole Van Israël discusses X-ray abnormalities within the cardiovascular and respiratory systems of cardiac patients. This includes a discussion on how to measure heart size and how to identify and interpret lung patterns.
Participants can then receive a CPD certificate by completing the quiz for this session. The Cardio Academy CPD website is free of charge and can be accessed on www.cardioacademy.cevalearn.com.
In addition, the first four sessions can still be accessed which cover the Pathophysiology of Mitral Valve Disease by Adrian Boswood, Clinical Examination of the Cardiac Dog by Gérard Le Bobinnec and Thoracic X-rays - How to Proceed and Thoracic X-rays - Normal Features by Nicole Van Israël.
For further information, please contact your local Ceva account manager.
Virbac has launched a new 12 month version of Suprelorin, the reversible medical castration implant for dogs, widening the options for clients seeking an alternative to surgical castration.
Product manager Chris Geddes MRCVS said: "The launch of Suprelorin 12 gives practices the chance to offer dog owners a more convenient castration option. The implant renewal can now be included with their dog's annual boosters or health check.
"The slow-release implant is inserted at the back of the neck in the same manner as a microchip. There is no anaesthetic, no surgery and no scarring. The current implant, which contains 4.7mg active and lasts for around 6 months after insertion, will continue to be available for those wanting a more brief solution or as a trial.
"Deslorelin is a GnRH superagonist which causes suppression of LH/FSH, and therefore testosterone production, leading to temporary infertility."
For further information on Suprelorin/12, please call and ask to speak to one of our veterinary advisors on 01359 243243, or contact your local Virbac territory manager.
VetSurgeon member Neil Forbes FRCVS, Specialist in Avian Medicine at Vets Now Referrals, has been dealing with a rather interesting case: an owl that swallowed a sock.
John Dowling, the owner of a falconry business and keeper of the 13 week old Indian eagle owl called Lydon noticed he was not eating properly, and then looked dazed and confused when taking part in the Stonehouse Horticultural Show & Summer Jolly. After the show, Lydon looked like he was trying to vomit but couldn't, so John took him to Vets Now Referrals in Swindon for a consultation.
Neil examined Lydon and found there was a hard swelling in his abdomen. Radiographs confirmed a bloated and very full stomach. The decision was taken to operate on Lydon to remove whatever was inside. Fearing a growth or tumour, Neil was rather surprised to find instead a smelly old sock in Lydon's stomach. With the sock successfully removed, Lydon was able to go home a few hours later, none the worse for his experience.
Lydon's owner, John, said: "Lydon is a hand-reared Indian eagle and is often in and around the house. The sock is a toy he has played with since he was a owlet, and never did I think he would, or could, have eaten it!
"I was obviously surprised when Neil found the sock in Lydon's stomach but more relieved than anything. I feared the worst but was delighted to find out it wasn't something more sinister."
Neil said: "Never in my 28 years of avian medicine experience have I treated an owl that swallowed a sock, it's just unheard of. Thankfully John brought Lydon into our clinic for a consultation upon suspicion something wasn't quite right and we were able to remove the sock preventing further health deterioration.
"We would always advise owners of pets to be careful when leaving items around the house, as you can never predict how mischievous pets can be."
BCF Technology has launched a new bovine reproduction clinical booklet which can now be ordered free from the company.
BCF says the booklet has been specifically designed as a reference guide for the reproductive tract of the cow, providing key clinical commentary and scanning images to show various stages of the fertility and reproductive processes.
The booklet was written by Kimberly Palgrave, BS BVM&S RCVS, BCF's in-house vet, and aims to help the user understand the value in using ultrasound for heard fertility management.
The company says the booklet provides essential information which will be useful to its Easi-Scan and Duo-Scan customers. The correct evaluation of the bovine reproductive tract is an essential aspect of both beef and dairy herd management and this 16 page booklet could help the user either to decide or reaffirm its interpretation.
Kimberly said: "This booklet really demonstrates BCFs commitment to learning and hopefully it will provide a quick reference guide to be used on the farm. It's ideal for students and those new to using ultrasound for cattle reproduction."
To order your free copy, visit the BCF website http://www.bcftechnology.com/, telephone +44 (0)1506 460023 or email info@bcftechnology.com.
A research project funded by The Horse Trust has made important discoveries about how two peptides regulate the inflammatory response in horses. This knowledge could help with the development of improved anti-inflammatory drugs, which are used to treat a wide range of conditions in horses.
The research project was led by Professor Fiona Cunningham at the Royal Veterinary College in Hertfordshire and Dr Karen Rickards at the Donkey Sanctuary in Sidmouth, assisted by Dr Andrew Brooks at the RVC, and by Dr Kirstie Pickles, now at the Royal (Dick) School of Veterinary Studies in Edinburgh.
Inflammation is associated with a wide range of equine diseases, including recurrent airway obstruction, laminitis and sweet itch. Anti-inflammatory drugs, such as glucocorticosteroids, mainly work by blocking the formation and/or actions of compounds produced in the horse's body that cause inflammatory responses. However, these drugs are not always effective and can have unwanted side effects.
This research, funded by The Horse Trust, aimed to find out more about two naturally-occurring peptides - chains of amino acids that are shorter than proteins - known as annexin-1 and CXCL8. Both have been shown to affect the inflammatory response but little research has been done on their effects in horses. In the long term, knowing more about these compounds could help in the development of new anti-inflammatory drugs with fewer side effects.
During inflammation, neutrophils (a type of white blood cell) stick to the cells lining blood vessels and migrate into inflamed tissue, where they ingest and break down harmful agents. Using techniques that mimic these events, CXCL8 was found to cause adherence and migration of horse neutrophils. However, when it was used in combination with another pro-inflammatory substance, neutrophil migration and adherence were markedly decreased. This suggests that attempts to reduce inflammation by blocking the actions of CXCL8 might not be as beneficial as had been thought.
At the start of the project, the researchers had no information about horse annexin-1, other than its gene sequence, so their first step was to develop a method to detect the peptide in white blood cells. They established that it was present and, as horse annexin-1 has not yet been synthesised, they used a synthetic peptide derived from annexin-1, Ac2-26, to look at the effects on horse neutrophils.
They found that Ac2-26 decreased neutrophil adherence and migration in response to other pro-inflammatory compounds, although at high concentrations the peptide itself caused some cell activation, thereby increasing inflammation. They also found that dexamethasone (a glucocorticosteroid) increased the levels of annexin-1 in cells, indicating that, as in humans, this class of drugs is likely to act in part through the formation of annexin-1.
These findings suggest that the use of compounds which mimic the actions of annexin-1 may have limitations as anti-inflammatory drugs. As glucocorticosteroids partly work by forming annexin-1, further research is needed in order to find out how annexin-1 will act in the horse's body and establish how its formation contributes to the beneficial effects of these drugs.
Professor Cunningham said: "This Horse Trust-funded research has resulted in some very interesting findings about how inflammatory cells are regulated in horses. The receptors that annexin-1 and CXCL8 act upon could be targets for new equine inflammatory drugs, but more research is needed first to fully understand their actions and how they produce these effects."
The team's research has been accepted for publication by the journal Veterinary Immunology & Immunopathology.
Kruuse UK has announced that it will be launching its new Android telemetric ECG system at BEVA 2011.
The original Televet 100 supports transmission of ECG data to a range of approx 100m (330ft), allowing recording and displaying of real time data only within a confined lunging or riding arena. By linking this system to a mobile network via 3G Android phone and a Windows 7 based tablet PC, the new Televet system overcomes this range limitation.
The new system requires the rider/horse to carry a 3G mobile phone which transmits data over the mobile internet, allowing the veterinary surgeon to display and record real time data on any PC/laptop with internet access or mobile internet connection. This also includes GPS information collected by the phone allowing the ECG, heart rate and velocity of the horse to be displayed in parallel.
The Android Telemetric ECG system is specifically targeted towards veterinary applications in the field of sports horses where extended range is particularly useful, such as endurance riding, three day eventing and racing.
Televet software can now also be integrated in Dicom infrastructures in practice for data capture and recording.
Sarah Stokes, Kruuse Equine Territory Manager said: "the flexibility and simplicity of the system along with immediate access to ECG data of patients will be an invaluable diagnostic tool for UK vets allowing vital support for patients and owners wherever they are."
Visitors to the Kruuse stand at BEVA 2011 will also have the chance to win an Acer ICONI W500 tablet worth £500.
Vetericyn VF, the vet-only wound and skin care spray from Innovacyn has been named product of the year by Animal Health International, one of the world's largest food and companion animal health distributors.
Commenting on the award, Innovacyn said: "for an organisation the size and reputation of Animal Health International to give this top honour to Vetericyn is a great vindication of the product's efficacy but also the very positive feedback they have received from professional users."
Vetericyn VF is available throughout the UK from all the leading veterinary wholesalers. Further technical resources are available at: www.vetericyn.com/veterinarians or email enquiries to uk@vetericyn.com
Boehringer Ingelheim Vetmedica, manufacturer of the equine pergolide Prascend, has joined forces with the British Horse Society, Redwings Horse Sanctuary and World Horse Welfare to launch the 'Talk About Cushing's (TAC)' campaign.
The initiative, which will take place throughout September and October 2011, is aimed at raising awareness of Cushing's Disease and its clinical signs, perhaps the most familiar of which is hirsutism (abnormal hair growth, or delayed shedding). Horse owners can download a £15 money-off voucher from http://www.talkaboutcushings.co.uk/ throughout the TAC initiative, which can be redeemed through their veterinary practice against blood test costs.
Boehringer says Equine Cushing's Disease, also known as Pituitary Pars Intermedia Dysfunction (PPID), is the most common endocrine disorder in older horses and ponies1 ,and that some estimates suggest over 15% of horses and ponies over 15 years of age are affected2.
Unfortunately, the initial stages of Cushing's Disease are often difficult to detect, delaying the maximum benefit of early diagnosis and intervention. Blood testing is increasingly used to detect the disease and confirm diagnosis, however many horses with clinical signs, including recurrent laminitis, still go undiagnosed.
Craig Beck, vet and equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "More than 80% of horses suffering from laminitis may have an underlying endocrine disorder, such as Cushing's Disease3.
"The TAC campaign will raise awareness of Cushing's Disease amongst both veterinary professionals and owners. It should make it easier for vets to go ahead with endocrine testing in horses and ponies with recurrent laminitis, diagnosing and treating earlier in the course of the disease."
Lee Hackett, head of welfare at the BHS, added: "Cushing's Disease is relatively common in horses yet in our experience it frequently goes undiagnosed and untreated. This is why we are fully behind the 'Talk About Cushing's' campaign - anything that raises awareness and understanding of this disease has to be of benefit to equine welfare."
Redwings' head of veterinary services Nicky Jarvis said: "At Redwings we have many horses over the age of 15, all living very happy and healthy lives. 'Old age' is not in itself a disease so when a geriatric horse loses condition or appears unwell there is always an underlying cause. If a horse continually succumbs to laminitis or loses weight, Cushing's Disease could be one explanation. However, with early diagnosis, good management and the correct treatment a horse with Cushing's can live comfortably for many years."
"Early diagnosis of Cushing's Disease can be of great benefit, other conditions such as laminitis are often associated with it and it is important that clinical signs are recognised and treated appropriately. World Horse Welfare supports the 'Talk About Cushing's' campaign as it will help people to recognise the signs and take the right action to prevent horses from suffering," concludes Tony Tyler, deputy chief executive, World Horse Welfare.
Backed by an advertising and PR campaign in the equine consumer media, Boehringer Ingelheim Vetmedica has produced a marketing pack for veterinary practices to use in the run up to, and during TAC. This includes leaflets, invoice stickers, a veterinary practice toolkit featuring an owner evening presentation, editorial copy for newsletters and websites and images to support the campaign.
For further information on TAC or Prascend, the first licensed product for the treatment of Cushing's Disease, please visit http://www.talkaboutcushings.co.uk/, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
References
1. Donaldson et al. “Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis”. JAVMA, Vol 224, No. 7, April 1, 20042. McGowan. “Diagnostic and Management Protocols for Equine Cushings Syndrome” In Practice, November/December 20033. McGowan. “Epidemiology and Clinical Perspectives of Endocrinopathic Laminitis”, BEVA Congress 2009
Dechra Veterinary Products has launched Celox Veterinary, a product which stops arterial or venous haemorrhage within 3 minutes, described as 'revolutionary' by the company.
Celox Veterinary is available in both a granule formulation and in two sizes of gauze. The granules can be poured into a wound. Once pressure is applied, a clot forms and arterial and venous haemorrhage is stopped within three minutes, independent of the body's normal clotting processes. Celox Veterinary Gauze has the granules ready bonded onto its surface for ease of use.
Dechra says the product works by bonding with red blood cells and gelling with fluids to produce a robust clot which sticks to moist tissue to plug the bleeding site. It can be helpful in treating a wide range of veterinary cases including:
Celox Veterinary is made from chitosan, a natural polysaccharide and by-product of the shrimp industry. It generates no heat while in use and small amounts of residual material left in the body are naturally metabolised.
Dechra Product Manager Rachel Horton said: "Wound care is an area in which Dechra is known for its innovative product range. We are delighted to take this to the next level by offering this revolutionary treatment to vets and believe it will soon establish itself as an efficacious tool when they are faced with significant injuries and severe bleeding."
For further information on Celox Veterinary, please contact your Territory Manager or call Dechra direct on (01939) 211200.
An ectoparasitology working group has been set up to provide a set of practical guidelines for veterinary surgeons across Europe.
The group, which has been established to bring together best practice strategies in the light of changing ectoparasite threats met for the first time earlier this year.
Headed by Doctor Marie-Christine Cadiergues, lecturer, researcher and Professor in dermatology at the National Veterinary School of Toulouse in France, and hosted by Virbac, the group of six leading independent experts from across Europe - including Dr Ross Bond from the RVC - has been tasked with developing strategies which can be applied by vets when advising their clients.
Virbac's small animal ectoparasitology product manager Victoria Hudson explains that using evidence-based data where possible, the aim of the group is to produce a clear, practical set of guidelines: "These will cover treatment efficacy, practicability for client education and compliance, impact in terms of animal welfare, public health and potential resistance, and a decision tree covering a wide range of scenario presentations to define the optimal antiparasitic treatment options."
Dr Bond adds that despite the very common occurrence of flea and tick infestations in pets, control strategies can be challenging depending on individual circumstances of the case: "It is anticipated that these guidelines will assist busy veterinary practitioners in their selection of the optimal control strategy."
An initial report is expected in the press in a few weeks time.
Boehringer Ingelheim VetMedica has published its equine endocrine webinars online for veterinary professionals to view on demand at www.prascend.co.uk/webinars.
The webinars, which cover 'Diagnostic challenges in equine endocrine disease', presented by equine internal medicine specialist Andy Durham from the Liphook Equine Hospital, and 'A problem-based approach to equine laminitis', presented by equine internal medicine specialist Dr Catherine McGowan from the University of Liverpool, are each one hour long.
Participants will each receive CPD certificates for participation.
The Veterinary Development Council (VDC) is conducting a survey to investigate the role of paraprofessionals and technicians in veterinary practice, and is asking vets in large animal, equine, and mixed practices to complete a short survey.
The VDC says that information from the survey will help inform discussions on the regulation of technicians.
The survey will take between 5 and 10 minutes to complete and can be found on the BVA website at www.bva.co.uk/vdc. The BVA has also emailed the survey directly to practices.
The survey has been devised by the VDC working group looking at the role of the veterinary-led team, chaired by BVA Past President Professor Bill Reilly. This is one of three working groups that will report to the VDC:
Professor Reilly said: "The relationship between veterinary surgeons and technicians is vital but it varies from practice to practice.
"The working group on the role of the veterinary-led team aims to take a snapshot of how services, such as artificial insemination and foot trimming, are currently delivered, and gauge how veterinary surgeons feel about other services being delivered by non-veterinarians in the future.
"I hope veterinary surgeons in large, mixed and equine practice will take 10 minutes to complete our survey to help us map the current use of technicians in veterinary practice and help shape our future discussions."
Lanes Health, manufacturer of the mobility supplement, LitoVet, has announced the nominees for the inaugural Litovet Equine Scientific Achievement Award, part of the annual Animal Health Trust (AHT) awards.
The award which has been set up to recognise a person or group whose clinical or scientific work has made a substantial difference to the equine veterinary world will be judged by a panel of leading veterinary surgeons and scientists.
The nominees are:
Peter Clegg - MA VerMB PhD CertsES DepEVCS MRCVS. Dr Clegg is Professor of Equine Surgery and Deputy Head of the Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, The University of Liverpool. Peter's current research focus is equine orthopaedics, in particular identifying the basic mechanisms of injury and repair in equine joints and tendons. He has supervised 13 successful PhD students and is currently supervising a further nine.
Andy Durham BSc, BVSc, DEIM, Dipl.ECEIM, MRCVS (RCVS & European Specialist in equine internal medicine). Liphook-based Andy Durham exemplifies the premise that veterinarians in practice can maintain an active interest in current research, undertake clinically relevant research projects, interact with researchers on an international stage and contribute to CPD through scientific papers, book chapters and lectures.
Tim Mair BVSc PhD DEIM DESTS DipECEIM MRCVS. Dr Mair ha been innovative in veterinary practice (e.g., an early adopter of standing magnetic resonance imaging [MRI]), has an extensive publication list recently focusing on evidence-based medicine for colic, but spanning the full breadth of common medical disorders in horses. He has made an enormous contribution to veterinary practice within both Europe and America in his role as Editor of Equine Veterinary Education.
Chris Proudman MA VetMB PhD CertEO FRCVS.Dr Proudman is Professor of Equine Studies at the University of Liverpool. His research interests are related to the aetiology and surgical management of acute intestinal disease (colic) in the horse: specifically, the diagnosis of intestinal parasites associated with colic and understanding dietary determinants of colic. Most recently this has involved using metabolomics and molecular microbiology to investigating the intestinal microbiota and its response to dietary change.
The LitoVet Equine Scientific Achievement Award can be granted to any individual or group that is currently undertaking, or has successfully implemented within the past ten years, one or more clinical or other research projects which has, or will, make a significant contribution to equine health and welfare.
The award will be presented to the recipient, or recipients, at the UK Equestrian Awards held at the Lancaster London on Thursday 3 November 2011.
Merial has announced that its canine NSAID, Previcox, is now now uniquely licensed for the relief of pain and inflammation associated with dental surgery in dogs.
According to the company, an estimated 70% of dogs over 2 years of age may have some degree of periodontal disease1, and painful extraction of teeth is often necessary for the successful management of this condition.
Merial says that Previcox has been demonstrated to control the pain associated with dental surgery, in a double-blinded, controlled trial2 in which dogs underwent maxillary canine tooth extraction. The results showed that Previcox treatment significantly reduced pain scores post dental surgery, making it the only NSAID with a specific claim for relief of post-operative dental pain. Results of physical examination and blood testing also confirmed the peri-operative safety profile of Previcox, with no treatment-related adverse effects noted during the trial.
To find out more, contact your Merial Territory Manager on 0870 6000 123. For more information about Previcox visit www.previcoxfordogs.co.uk
1 Wiggs RB and Lobprise HB. Periodontology. In: Veterinary Dentistry, Principles and Practice. Philadelphia: Lippincott-Raven; 1997. p1872 Merial Internal data PR&D0116401.
Merial has released the results of a survey - carried out in conjunction with VetSurgeon.org - into the use of nutraceuticals for the management of canine joint problems.
The company says the total market for nutraceutical products remains strong, holding a value of £8.9 million* in the UK, and that this indicates that despite increasing economic pressures, nutraceuticals are still valued by veterinary surgeons and owners as an important part of the management approach to canine joint disease.
The survey generated 163 responses. Results showed that whilst 58% of canine patients with joint health problems received only NSAIDs for treatment, 28% of patients received both NSAIDs and a joint health nutraceutical and 14% received a nutraceutical alone, demonstrating the importance that veterinary practitioners place on the use of nutraceuticals. The survey also showed that on average, UK vets stock and recommend at least two nutraceutical products.
Supleneo flex Product Manager Claire Edmunds said: “This eshot survey yielded some interesting results and the email received the second highest recorded opening rate this year, indicating that it is a topic of great interest. The survey confirmed that vets are actively recommending nutraceuticals, alongside NSAIDs, for canine patients with joint health problems. These data also show that the market remains stable as the level of dispensing correlates well with our previous research. To encourage even more growth in this sector and support the launch of Supleneo flex we have produced a range of support materials, including the provision of samples, money off next purchase vouchers and a loyalty programme. In this way we can continue to support vets in their management of canine joint problems.”
For more information call Merial on 0870 6000 123 or contact your Territory Manager.
Companion Care has opened its 80th surgery, within the Ilford Pets at Home store.
Companion Care Vets managing director, Jane Balmain said: "The opening of our 80th surgery proves the success of our joint venture partner business model. At present the majority of our surgeries are located inside Pets at Home stores but we also have four very successful standalone surgeries. Our standalone surgery network is now being developed to create further exciting opportunities for future growth, with our first new standalone surgery opening in Scotland this December."
Joint venture partner and veterinary surgeon at Companion Care Vets Ilford Alberto Arciniega said: "Alongside the fantastic team we have on board, my partners Nick and Claire and I are extremely proud to be opening our second surgery here in Ilford. Having been partners at the Romford surgery since July 2009 we have seen the company grow consistently and successfully. We feel honoured to be opening the groups' 80th surgery and look forward to the challenge of managing both practices and to delivering outstanding veterinary care."
With 102 Joint Veterinary Partners, 83 of whom are veterinary surgeons, 12 veterinary nurses, 6 practice managers and 1 receptionist and a further 789 staff employed by the group Companion Care Vets is one of the largest veterinary employers in the UK. Dividend payments to joint venture partners in the 2010/2011 period totalled £2.181 million and the group says it plans to open a further 10 surgeries across the UK before the end of year.
A PR headache for Fortnum and Mason yesterday, as PETA employee Abi Izzard changed her name by deed poll to StopFortnumandMasonFoieGrasCruelty.com to try and shame the London store into stopping selling foie gras.
To produce foie gras, birds are force-fed several times per day in a controversial practice known as gavage, which causes their livers to swell to many times their normal size. PETA claims the practice causes the birds' livers to become diseased, that many animals bleed to death after their throats are punctured by force-feeding tubes, that surviving birds live in terror as they await the next assault, and become sick and lethargic.
However, Dr. Daniel Guemene, Director of Research & Senior Scientist at the National Agronomic Institute in France, says his research proves otherwise. In one study for example, stress levels in force-fed birds were guaged through the measurement of corticosterone blood levels. The study concluded that there was no significant increase in stress levels, except after the first instance of force-feeding, which researchers said was most likely due to holding the ducks, rather than the force-feeding. In addition, he claims to have demonstrated that ducks show no avoidance behaviour to the force-feeder or force-feeding, as would be expected if they feared these things.
The actor Roger Moore is a supporter of this girl's campaign. He said: "Many people know me as James Bond or 007, but I never went so far as officially changing my name from Roger Moore. I hope the young lady now known as StopFortnumAndMasonFoieGrasCruelty.com royally shames this store".
Elanco has announced the results of a challenge study which the company says demonstrates the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course1.
The study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two dose of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
According to Elanco, this is believed to be the first demonstration of cross protection by a current UK equine influenza vaccine against a Florida sub-lineage clade 2 reference strain.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade2.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of this challenge study provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE have identified as being of concern."
Duvaxyn IE-T Plus is an inactivated whole virus equine influenza vaccine, adjuvanted with an aqueous-based adjuvant. Elanco says that experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly-based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins in the vaccine3.
References:
Norbrook Laboratories has announced Arthritis Awareness Month, which will run from 15th October to 15th November 2011, during which the company will be running a series of special promotions and competitions.
Michelle Jones, Companion Animal Brand Manager said: "At Norbrook, we are focusing on arthritis during October when pet owner and veterinary practices can enjoy special promotions on arthritis treatment, enter competitions with a range of great prizes and receive expert advice from our own inhouse Veterinary Advisors on the dedicated Pet Healthcare section on our website."
Michelle added: "Our product range offers veterinary surgeons and pet owners a wide choice of treatments. Loxicom for cats and dogs is our meloxicam product available as an oral suspension or an injectable while Carprieve is our Carprofen product, available as an injectable for dogs and cats and in tablet form for dogs. We have also recently introduced a new liver-flavoured palatable tablet which is proven to be more successful in getting dogs to take the medication. In addition, Norbrook also supply a glucosamine supplement, Noractive, which can also be used for improving joint suppleness and mobility in cats and dogs."
More details about Arthritis Awareness Month will be sent to practices, or you can visit www.norbrook.com/vet-support/
Petsavers, the charitable division of the BSAVA, is calling for entries to its 2012 digital photography competition, this year themed 'Best Buddies'.
The competition is open to entries from pet owners and veterinary professionals alike. The judges will be looking for qualities like humour and character in the photos, as well as photographic skill.
If you need a little inspiration, you can see the winning images from previous years on the BSAVA website.
The competition has two categories: Adult (16 and over) and Junior (under 16). First prize in each category is £200 in photography vouchers, second prize is £100 in photography vouchers and third prize is £50 in photography vouchers. The closing date is Thursday 26 January 2012. To enter the competition, email your photographs to info@petsavers.org.uk. An application form must also be submitted; this can be emailed with your photograph or alternatively you can print and fax the form to BSAVA at 01452 726701.
Petsavers is also encouraging practices to help promote the competition by displaying leaflets in practice, and telling clients about it.
More information is available by emailing: info@petsavers.org.uk or visiting www.petsavers.org.uk/.
Eurovet Animal Health has launched a new product, Bovocycline 2000 mg pessary for cattle.
Bovocycline 2000 is the only veterinary licenced antibiotic pessary for the treatment of retained foetal membranes in cattle. It is licenced for the treatment of post parturient disorders in cattle, for administration after dystocia, retained foetal membranes (RFMs) and endometritis.
According to Eurovet, the incidence of retained foetal membranes in cows varies from zero to 25 per cent, but the average is around 4 per cent in most herds. RFMs result in reduced cow fertility and a higher risk of culling due to poor fertility. Pessaries are still considered the preferred treatment for vulval discharges in cattle by farmers.
Ruth Vernon, Technical Services Manager for Eurovet said: "The control of post partum problems in cattle is rarely straight forward, but it is great to have a veterinary licensed treatment designed specifically for this purpose, in one pessary that contains 2000mgs tetracycline".
For more information please contact Eurovet Animal Health. Tel: 01223 257933. E-mail: office@eurovet-ah.co.uk www.eurovet-ah.co.uk